Human BNP Fragment EIA from Biomedica Medizinprodukte GmbH

Supplier Page

Supplier Page from
Biomedica Medizinprodukte GmbH for
Human BNP Fragment EIA

Get Pricing

Description

Product Characteristics: The Biomedica human BNP Fragment EIA kit is a test that is intended for the quantitative measurement of B-type natriuretic peptide levels in human serum, EDTA plasma, citrate plasma and heparin plasma. The Biomedica BNP Fragment EIA is a highly recognized test with64 BNP Fragment ELISA specific publications to date.

Target Information: BNP is mainly expressed by ventricular myocardium in response to volume overload and increased filling pressure. BNP has a cleavable signal sequence. Mature BNP consists of 108 amino acids (proBNP or BNP-108), and undergoes cleavage resulting in physiologically active BNP-32 and additional C-terminal fragments, along with a physiologically inactive N-terminal peptide comprising amino acids 1-76, which is further degraded proteolytically.
BNP has a key role in cardiovascular homeostasis with biological actions including natriuresis, diuresis, vasorelaxation, and inhibition of renin and aldosterone secretion. A high concentration of BNP in the bloodstream is indicative of heart failure